Latest Posts › Infectious Diseases

Share:

Preparedness Policy Takes Shape: PREVENT Pandemics Act Enacted Ahead of PAHPA Reauthorization

On December 29, 2022, the President signed into law the Prepare for and Respond to Existing Viruses, Emerging New Threats and Pandemics Act (PREVENT Pandemics Act) as part of the Consolidated Appropriations Act, 2023 (P.L....more

[Podcast] Rare Disease; Rarer Organization: How EB Research Partnership Drives Rare Disease Research

In this episode of OnAir: Health Care, Akin Gump senior policy advisor Matthew Hittle and consultant Dr. Mario Ramirez welcome Michael Hund of EB Research Partnership....more

Life After Omicron: Critical COVID-19 Policy Areas to Watch in the Weeks Ahead

For the past two years, the United States government has had to deal with most major legislative and regulatory actions against the backdrop of the COVID-19 pandemic. In making policy, the federal government has been forced,...more

[Podcast] The Omicron variant: Where are we now, and what is the future for testing?

In this episode of OnAir: Health Care, Akin Gump health care senior policy advisor Matthew Hittle and consultant Dr. Mario Ramirez welcome Dr. Michael Mina, chief science officer for eMed, a digital point-of-care...more

[Podcast] Vaccine IP Fight; Delicate Dem Dynamics; Deciphering CDC

In this new episode of OnAir: Health Care, Akin Gump health care senior policy advisor Matthew Hittle and consultant Dr. Mario Ramirez welcome public law and policy partners Ed Pagano and Clete Willems to talk federal health...more

What’s Next for Nursing Homes: COVID-19 and Outlook for Action

Key Points - Congress and government watchdogs have conducted considerable work to date investigating the COVID-19 response pertaining to nursing homes. - Stakeholders should look to previously introduced...more

Administration Pledges to Purchase More Vaccine; Important Nuances Exist in the Details

The Biden administration announced on Tuesday, January 26 that it plans to purchase 200 million additional doses of vaccine against COVID-19. Additionally, the administration announced that it plans to increase shipments of...more

7 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide